Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share News

12345678910

Allergy Therapeutics Interim Loss Widens But Germany Pushes Revenue Up

26th Sep 2018 12:42

LONDON (Alliance News) - Allergy Therapeutics PLC on Wednesday said its loss widened in the first half of 2018, but revenue rose on strong performance in Germany and a strengthening of the company Read More

Allergy Therapeutics To Raise GBP11 Million Via Share Issue (ALLISS)

19th Jul 2018 11:08

LONDON (Alliance News) - Allergy Therapeutics PLC said Thursday that it will raise up to GBP10.6 million via placing and subscription.The pharmaceutical company focused on allergy vaccines Read More

Allergy Therapeutics Reveals Good Results From Dust Mite Allergy Tests

29th May 2018 11:19

LONDON (Alliance News) - Biotechnology firm Allergy Therapeutics PLC said it will present positive new data on its dust mite allergy treatment at a congress in Germany on Tuesday.Allergy is Read More

Allergy Therapeutics Reports Positive Results From Grass Pollen Study

21st May 2018 11:49

LONDON (Alliance News) - Allergy Therapeutics PLC said Monday it saw positive results from its grass pollen allergy treatment phase II dose ranging study as it prepares to commence in phase III it Read More

Allergy Therapeutics Gets Positive Indications In Latest MCT Study

14th May 2018 12:24

LONDON (Alliance News) - Biotechnology firm Allergy Therapeutics PLC on Monday said it has received positive new data in a study investigating its microcrystalline tyrosine-based results, it said, Read More

DIRECTOR DEALINGS: Allergy Therapeutics Non-Executive Lifts Stake

16th Mar 2018 17:30

LONDON (Alliance News) - Pharmaceutical company Allergy Therapeutics PLC said Friday Non-Executive Director Tunde Otulana acquired shares on Thursday.Otulana acquired a Read More

Allergy Therapeutics Profit Falls On Costs As Pivotal Year Looms

7th Mar 2018 13:42

LONDON (Alliance News) - Allergy Therapeutics PLC said Wednesday half year profit fell due to higher research and development costs, as the company prepares for 2018 clinical Read More

Allergy Therapeutics' House-Dust Mite Allergy Vaccine Trial Approved

14th Feb 2017 08:49

Read More

Allergy Therapeutics Granted EU Patent For Microcrystalline Tyrosine

2nd Nov 2016 09:29

Read More

DIRECTOR DEALINGS: Allergy Therapeutics Chairman Lifts Stake

29th Sep 2016 11:55

Read More

DIRECTOR DEALINGS: Allergy Therapeutics Finance Boss Buys First Shares

28th Sep 2016 10:41

Read More

Allergy Therapeutics Expects Revenue Rise Despite Euro Weakening

13th Jul 2016 08:43

Read More

Allergy Therapeutics Welcomes Positive Follow-Up Results For Acarovac

8th Jul 2016 07:26

Read More

WINNERS & LOSERS SUMMARY: easyJet And Foxtons In Post-Brexit Warnings

27th Jun 2016 09:51

Read More

Allergy Therapeutics Sees Delayed US Market Launch For GrassMATAMPL

27th Jun 2016 09:06

Read More

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

10th Jun 2016 07:41

Read More

Allergy Therapeutics Gets Positive Birch Pollen Treatment Results

9th May 2016 06:57

Read More

NetScientic Poaches New Finance Boss From Allergy Therapeutics

5th Apr 2016 08:12

Read More

Allergy Therapeutics Finance Director Ian Postlethwaite Resigns

17th Mar 2016 09:08

Read More

BROKER RATINGS SUMMARY: Jefferies Starts Metro Bank With Buy Rating

10th Mar 2016 09:33

Read More

12345678910
FTSE 100 Latest
Value9,552.53
Change37.53